ESR10 small


In the framework of the European collaborative project ND4ID (New diagnostics for Infectious Diseases), Biocartis and UA will perform joint research to develop an integrated system to enable sequencing from pathogens directly from a blood sample without the need for blood culture. An integrated sample enrichment technology, earlier developed for PCR analysis, will be extended to enable sequencing based detection, including both targeted re-sequencing and metagenomic approaches to enable species and/or antibiotic resistance identification.

Your tasks will comprise of:

To obtain a good understanding of the clinical need with regard to sequencing technologies enabling you to translate that knowledge into technological developments and system requirements.

To think out of the box and to come up with inventive technical solutions which enable the biological processes to run on the platform and deliver an answer to the unmet clinical need.

To bridge the expertise at Biocartis and University of Antwerp and to maintain good communication with experts working in both organizations.

To actively participate in the network-wide training program of the ND4ID project, building up knowledge on all aspects of the diagnostic development process and to transfer that knowledge to people within and outside the organization.

What we offer

A challenging job in an exciting environment, working for top entrepreneurs in the biotech industry.

A close association with clinical practice through the collaboration with the University of Antwerp and the University hospital Antwerp.

Being part of a multidisciplinary group of early stage researchers through the ND4ID program. In total 15 researchers in various research institutes throughout Europe will be part of this program, each investigating a major hurdle in current diagnostic developments.

The opportunity to obtain a PhD. At the start of the project, a personal mentor will be assigned and a career development plan will be jointly developed.

An extensive network-wide training program through the ND4ID project, consisting of 6-monthly workshops, lectures, challenges and hands-on training sessions covering clinical, technological, ethical, regulatory and commercial perspectives on the development of IVDs for infectious diseases.

A position where you have the freedom to shape your work and to shape your job. Your input and creativity are highly appreciated.

How to apply?

Please apply by e-mail (motivational letter and CV in English) to using the job ID ND4ID as a reference.

Anticipated start date: April-May 2016

Selection procedure

Initial screening based on CV and letter

Interview(s) with selection committee

Approval by the ND4ID Supervisory Board

Selections will be made regardless of gender, nationality, religion, ethnicity and cultural background, but aiming for a good balance among the group.

  • Biocartis NV Generaal De Wittelaan 11B3 2800 Mechelen Belgium
  • University of Antwerp – Vaccine and Infectious Disease Institute
    Campus Drie Eiken – Universiteitsplein 1
    2610 Antwerpen

Specific profile requirements

  • Strong molecular biology and microbiology knowledge including sequencing strategies
  • Able to work independently (planning and executing experiments)
  • Interest in microfluidics and engineering and eagerness to learn and interact in a multidisciplinary team to identify and solve problems
  • Creativity to think out-of-the box to enable solutions to be tested
  • Interaction with non-technical people within the program and other departments in the company as well as with the university hospital
  • Strong and proven knowledge of the English language is a must
  • Willingness to travel
  • Candidates shall, at the time of recruitment be in the first four years (full-time equivalent research experience) of their research careers and have not been awarded a doctoral degree.
  • Mobility rule: at the time of recruitment, researchers must not have resided or carried out their main activity (work, studies, etc) in Belgium for more than 12 months in the 3 years immediately prior to the reference date.